Screener
Mirum Pharmaceuticals, Inc. MIRM PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 636,310 | 549,684 |
| Restricted cash | 1,734 | 1,482 |
| Long-term investments | 123,030 | 8,105 |
| Property and equipment, net | 2,251 | 1,862 |
| Operating lease right-of-use assets | 12,024 | 8,741 |
| Intangible assets, net | 247,388 | 260,921 |
| Other assets | 22,244 | 12,018 |
| Total assets | $1,044,981 | $842,813 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s PP&E (net)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported PP&E (net) of $2.25M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s PP&E (net) increased by 91.2% year-over-year, from $1.18M to $2.25M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s PP&E (net) has grown at a 7.6% compound annual growth rate (CAGR), from $1.29M to $1.86M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Mirum Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude